|
Volumn 39, Issue 6, 2014, Pages 1120-1123
|
Effects of Xihuangwan in assistant treatment of patients with advanced breast cancer
|
Author keywords
Advanced breast cancer; Long term effect; Short term effect; Xihuangwan
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CHINESE DRUG;
CYCLOPHOSPHAMIDE;
EPIRUBICIN;
PACLITAXEL;
UNCLASSIFIED DRUG;
XIHUANGWAN;
ADVANCED CANCER;
ARTICLE;
BREAST CANCER;
BREAST SURGERY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
CONTROLLED STUDY;
DRUG EFFICACY;
FOLLOW UP;
HUMAN;
LESION STABILIZING RATE;
LONG TERM CLINICAL EFFICACY;
MAJOR CLINICAL STUDY;
ONCOLOGICAL PARAMETERS;
OVERALL SURVIVAL;
PROGRESSION FREE SURVIVAL;
RANDOMIZED CONTROLLED TRIAL;
SHORT TERM CLINICAL EFFICACY;
UNSPECIFIED SIDE EFFECT;
BREAST NEOPLASMS;
DISEASE-FREE SURVIVAL;
DRUGS, CHINESE HERBAL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MIDDLE AGED;
NEOPLASM STAGING;
RETROSPECTIVE STUDIES;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 84902129027
PISSN: 10015302
EISSN: None
Source Type: Journal
DOI: 10.4268/cjcmm20140633 Document Type: Article |
Times cited : (7)
|
References (5)
|